Quarterly report pursuant to Section 13 or 15(d)

Sharebased Compensation (Details Narrative)

v3.23.1
Sharebased Compensation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Restricted stock options available to be granted under amended plan       4,717  
Restricted Stock options available to be granted under amended plan       4,098  
Directors and officers [Member]          
Restricted shares granted based on fiscal 2022 performance       551  
2013 Incentive Stock Plan [Member]          
Shares authorized to be granted under amended plan       15,000  
Restricted stock available to be granted under amended Plan       7,500  
Stock option available to be granted under amended Plan       7,500  
Restricted common stock shares granted under amendment plan       760  
Restricted stock and stock options available to be granted under amended plan       8,815  
Increased restricted stock and stock option grants under amended plan       10,000  
Stock Option [Member]          
Stock options granted under amended plan       524  
Warrant [Member]          
Weighted average remaining contractual life   2 years 6 months   2 years 3 days  
Weighted average exercise price per share   $ 2   $ 2  
Warrants outstanding   77   77  
Warrants [Member] | Stock Option [Member]          
Restricted Stock options available to be granted under amended plan       435  
Share-based compensation expense $ 38   $ 76 $ 325 $ 151
Unrecognized compensation expense       $ 510  
Weighted average vesting period       3 years 8 months 8 days  
Restricted Stock [Member]          
Share-based compensation expense $ 88   $ 76 $ 175 $ 148
Unrecognized compensation expense       $ 624  
Weighted average vesting period       3 years 21 days